- Project leader and project manager on a translational Program Project grant (P01) to develop a novel inhaled therapeutic agent for mucus-associated lung disease; - Responsible for planning and execution of all IND-enabling activities towards First-in-Human clinical trials: lead selection, manufacturing, formulation and nonclinical toxicology; - Organize and manage activities of multiple academic sites and contract research organizations; IP portfolio management.

Organized and managed Catalyst Awards, academic-industry alliances, and educational initiatives that facilitate translation of academic discoveries into valuable biomedical products.https://ctsi.ucsf.edu/catalyst

- Identified and oversaw submissions of grant proposals to government agencies, such as NIH, NIST, DoD, to support technology development. Three new technology development programs started based on successful awards.- Managed pre-clinical studies for development of a novel hemostatic dressing.- Implemented cell-based assays for studying cellular interactions with biomaterials.- Maintained IP portfolio, managed outside counsel.

Dissertation "Studies of electrostatic effects in proteins using chemically modified derivatives"